Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study
Authors
Keywords
Acetate-free biofiltration (AFB), Fibroblast growth factor 23 (FGF23), Hemodiafiltration
Journal
JOURNAL OF NEPHROLOGY
Volume 31, Issue 3, Pages 429-433
Publisher
Springer Nature
Online
2017-04-11
DOI
10.1007/s40620-017-0393-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study
- (2015) Maurizio Gallieni et al. JOURNAL OF NEPHROLOGY
- Semaphorin 3A serum levels are influenced by haemodialysis: What clinical significance?
- (2015) Valeria Cernaro et al. NEPHROLOGY
- Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis
- (2015) Jelmer K. Humalda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients
- (2014) Bernhard O. Bielesz et al. CLINICAL BIOCHEMISTRY
- FGF23 is associated with disease severity and prognosis in chronic heart failure
- (2014) Gerhard Poelzl et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The future of phosphate binders: a perspective on novel therapeutics
- (2014) Valeria Cernaro et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients
- (2013) Ting Jia et al. AMERICAN JOURNAL OF NEPHROLOGY
- Acetate-Free Biofiltration Reduces Intradialytic Hypotension: A European Multicenter Randomized Controlled Trial
- (2013) Nicola Tessitore et al. BLOOD PURIFICATION
- Hémodiafiltration online et hypoparathyroïdie chez l’enfant : une série de cas monocentrique
- (2013) Thomas Pérouse de Montclos et al. Nephrologie & Therapeutique
- Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis
- (2013) J. Zaritsky et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Changes in circulating biomarkers during a single hemodialysis session
- (2012) Tae Yamamoto et al. Hemodialysis International
- An update on uremic toxins
- (2012) N. Neirynck et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis
- (2012) Laure Patrier et al. JOURNAL OF NEPHROLOGY
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases
- (2011) J. Bernheim et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients
- (2010) DAVIDE BOLIGNANO et al. NEPHROLOGY
- Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients
- (2007) P. Urena Torres et al. KIDNEY INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started